Ophthalmology
Volume 117, Issue 9 , Pages 1674-1683, September 2010

Predicting the Onset of Glaucoma:

The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study

  • Robert N. Weinreb, MD

      Affiliations

    • Department of Ophthalmology, University of California-San Diego, Hamilton Glaucoma Center, La Jolla, California
    • Corresponding Author InformationCorrespondence: Robert N. Weinreb, MD, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946
    • ,
  • Linda M. Zangwill, PhD

      Affiliations

    • Department of Ophthalmology, University of California-San Diego, Hamilton Glaucoma Center, La Jolla, California
    • ,
  • Sonia Jain, PhD

      Affiliations

    • Family and Preventive Medicine, University of California-San Diego, La Jolla, California
    • ,
  • Lida M. Becerra, MS

      Affiliations

    • Family and Preventive Medicine, University of California-San Diego, La Jolla, California
    • ,
  • Keri Dirkes, MPH

      Affiliations

    • Department of Ophthalmology, University of California-San Diego, Hamilton Glaucoma Center, La Jolla, California
    • ,
  • Jody R. Piltz-Seymour, MD

      Affiliations

    • University of Pennsylvania Health Systems, Bristol, Pennsylvania
    • ,
  • George A. Cioffi, MD

      Affiliations

    • Ophthal-Discoveries in Sight, Devers Eye Institute, Portland, Oregon
    • ,
  • Gary L. Trick, PhD

      Affiliations

    • Ophthalmology, Henry Ford Health System, Detroit, Michigan
    • ,
  • Anne L. Coleman, MD, PhD

      Affiliations

    • Jules Stein Institute-UCLA, Los Angeles, California
    • ,
  • James D. Brandt, MD

      Affiliations

    • University of California-Davis Eye Center, Sacramento, California
    • ,
  • Jefferey M. Liebmann, MD

      Affiliations

    • Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York
    • ,
  • Mae O. Gordon, PhD

      Affiliations

    • Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • Michael A. Kass, MD

      Affiliations

    • Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • OHTS CSLO Ancillary Study Group

Received 13 November 2009; received in revised form 15 March 2010; accepted 17 March 2010. published online 14 July 2010.

Available online: July 14, 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Manuscript no. 2009-1585.

 Financial Disclosure(s): The authors have made the following disclosures.

 R.N. Weinreb - Support - Heidelberg Engineering, GmbH.

 L.M. Zangwill - Support - Heidelberg Engineering, Heidelberg, Germany; Carl Zeiss Meditec Inc, Dublin, CA.

 J. Piltz - Support - Seymour, Pfizer, Inc., Alcon Laboratories, Inc., Allergan, Inc., Merck.

 G.A. Cioffi - Consultant - Allergan, Inc., Pfizer Inc, C.

 G.L. Trick - Consultant - Allergan, Inc.

 A.L. Coleman - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.

 J.D. Brandt - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.; Lecturer - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.

 J.M. Liebmann - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Optovue, Inc., Heidelberg Engineering, GmbH, Pfizer, Inc., Topcon Medical Systems, Inc., Diopsys, Inc.; Support - Carl Zeiss Meditec, Inc.; Diopsys, Inc., Heidelberg Engineering, GmbH, Optovue, Inc., Pfizer, Inc., Topcon Medical Systems, Inc.

 M.A. Kass – Consultant – Pfizer, Inc.

 Supported by NIH/NEI grants, EY11158 (RNW), (EY09341, EY09307 [MOG, MAK]), Horncrest Foundation awards, NIH Vision Core Grant P30 EY02687, Merck Research Laboratories, Pfizer Inc, White House Station, New Jersey.

PII: S0161-6420(10)00323-4

doi:10.1016/j.ophtha.2010.03.044

Ophthalmology
Volume 117, Issue 9 , Pages 1674-1683, September 2010

Article Tools

* Image Usage & Resolution